FOLH1 and posterior cortical atrophy: In summary, TL-PSMAp, and PSMA-TVp of 18F-PSMA-1007 PET/CT volumetric parameters in patients with newly diagnosed PCa differed among patients with different numbers of metastatic lesions (no metastasis, oligometastatic, and extensive metastasis) and were more advantageous than SUVmax, Therefore, 18F-PSMA-1007 PET/CT should be considered in patients with newly diagnosed PCa before developing a treatment plan, and more attention should be paid to TL-PSMAp of metabolic volumetric parameters.